Try our Advanced Search for more refined results
July 02, 2018
Genentech, Inc. v. Eli Lilly and Company
Case Number:
3:18-cv-01518
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 23, 2021
Eli Lilly Loses $10M Fee Bid Over Genentech's Dropped IP Suit
A California federal judge on Tuesday rejected Eli Lilly & Co.'s bid for $10 million in attorney fees alleging Genentech Inc. dragged out litigation before dropping its patent suit over a psoriasis drug while noting Genentech unreasonably failed to tell the USPTO about a Federal Circuit decision weakening its claim to patent protection.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login